These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24007533)

  • 1. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery.
    Serrano-Villar S; Moreno S; Fuentes-Ferrer M; Sánchez-Marcos C; Avila M; Sainz T; de Villar NG; Fernández-Cruz A; Estrada V
    HIV Med; 2014 Jan; 15(1):40-9. PubMed ID: 24007533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.
    Bernal Morell E; Serrano Cabeza J; Muñoz Á; Marín I; Masiá M; Gutiérrez F; Cano A
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):648-53. PubMed ID: 27005326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
    Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
    J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment.
    Bernal E; Serrano J; Perez A; Valero S; Garcia E; Marín I; Muñoz A; Verdú JM; Vera C; Cano A
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19723. PubMed ID: 25397469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.
    Serrano-Villar S; Pérez-Elías MJ; Dronda F; Casado JL; Moreno A; Royuela A; Pérez-Molina JA; Sainz T; Navas E; Hermida JM; Quereda C; Moreno S
    PLoS One; 2014; 9(1):e85798. PubMed ID: 24497929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative CD4 count or CD4/CD8 ratio as a useful indicator for postoperative sepsis in HIV-infected patients undergoing abdominal operations.
    Xia XJ; Liu BC; Su JS; Pei H; Chen H; Li L; Liu YF
    J Surg Res; 2012 May; 174(1):e25-30. PubMed ID: 22225978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
    Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
    Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.
    Tedeschi R; Bortolin MT; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    J Clin Virol; 2012 Apr; 53(4):297-301. PubMed ID: 22244256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.
    Caby F; Guihot A; Lambert-Niclot S; Guiguet M; Boutolleau D; Agher R; Valantin MA; Tubiana R; Calvez V; Marcelin AG; Carcelain G; Autran B; Costagliola D; Katlama C
    Clin Infect Dis; 2016 May; 62(10):1297-1303. PubMed ID: 26908792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.
    Sainz T; Serrano-Villar S; Díaz L; González Tomé MI; Gurbindo MD; de José MI; Mellado MJ; Ramos JT; Zamora J; Moreno S; Muñoz-Fernández MA
    AIDS; 2013 Jun; 27(9):1513-6. PubMed ID: 23435292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.
    Castilho JL; Shepherd BE; Koethe J; Turner M; Bebawy S; Logan J; Rogers WB; Raffanti S; Sterling TR
    AIDS; 2016 Mar; 30(6):899-908. PubMed ID: 26959354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients.
    Calcagno A; Piconi S; Focà E; Nozza S; Carli F; Montrucchio C; Cattelan AM; Orofino G; Celesia BM; Morena V; De Socio GV; Guaraldi G;
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):338-342. PubMed ID: 28708810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.
    Saracino A; Bruno G; Scudeller L; Volpe A; Caricato P; Ladisa N; Monno L; Angarano G
    AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1178-84. PubMed ID: 25360575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
    Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
    PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.